Results 271 to 280 of about 11,256,402 (404)

The Tumour Glyco-Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment. [PDF]

open access: yesEur J Immunol
O'Neill A   +7 more
europepmc   +1 more source

Additional file 4: of Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation

open access: gold, 2019
Anton Selich   +6 more
openalex   +1 more source

A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33

open access: yesCarcinogenesis, 2018
L. Ding   +9 more
semanticscholar   +1 more source

Targeting the Spleen as an Alternative Site for Hematopoiesis [PDF]

open access: yes, 2019
Lim, Hong   +3 more
core   +1 more source

Construction of a Multitissue Cell Atlas Reveals Cell‐Type‐Specific Regulation of Molecular and Complex Phenotypes in Pigs

open access: yesAdvanced Science, EarlyView.
This research conducts an in‐depth investigation of cell‐type‐specific regulatory mechanisms underlying molecular and complex phenotypes through integrative analysis of multitissue single‐nucleus RNA sequencing, bulk RNA‐seq, and genome‐wide association study (GWAS) data in pigs.
Lijuan Chen   +31 more
wiley   +1 more source

Proteomic profiling of adipose-derived mesenchymal stromal cell response to novel compounds targeting the Laminin Receptor - PEDF interaction. [PDF]

open access: yesBiochem Biophys Rep
Figueiredo ML   +8 more
europepmc   +1 more source

Stromal gene signatures in large-B-cell lymphomas.

open access: yesNew England Journal of Medicine, 2008
G. Lenz   +50 more
semanticscholar   +1 more source

FAPα+ Macrophages Orchestrate Immune Evasion in Multiple Myeloma by Dual Regulation of PD‐L1 and T Cell Senescence

open access: yesAdvanced Science, EarlyView.
ABSTRACT Multiple myeloma (MM) is a hematologic malignancy driven by clonal expansion of malignant plasma cells. Despite the long‐term disease control achieved with immunotherapies in some patients, treatment resistance remains a major cause of disease relapse.
Huiyao Gu   +15 more
wiley   +1 more source

Therapeutic effects of mesenchymal stromal cell secretome in liver fibrosis with acute lung injury. [PDF]

open access: yesExp Biol Med (Maywood)
Martins ACRN   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy